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Objective: Epidemiological studies have shown an association between increased bone mineral density
(BMD) and osteoarthritis (OA), but whether this represents cause or effect remains unclear. In this study,
we used a novel approach to investigate this question, determining whether individuals with High Bone
Mass (HBM) have a higher prevalence of radiographic hip OA compared with controls.
Design: HBM cases came from the UK-based HBM study: HBM was deﬁned by BMD Z-score. Unaffected
relatives of index cases were recruited as family controls. Age-stratiﬁed random sampling was used to
select further population controls from the Chingford and Hertfordshire cohort studies. Pelvic radio-
graphs were pooled and assessed by a single observer blinded to case-control status. Analyses used
logistic regression, adjusted for age, gender and body mass index (BMI).
Results: 530 HBM hips in 272 cases (mean age 62.9 years, 74% female) and 1702 control hips in 863
controls (mean age 64.8 years, 84% female) were analysed. The prevalence of radiographic OA, deﬁned as
Croft score 3, was higher in cases compared with controls (20.0% vs 13.6%), with adjusted odds ratio
(OR) [95% CI] 1.52 [1.09, 2.11], P ¼ 0.013. Osteophytes (OR 2.12 [1.61, 2.79], P < 0.001) and subchondral
sclerosis (OR 2.78 [1.49, 5.18], P ¼ 0.001) were more prevalent in cases. However, no difference in the
prevalence of joint space narrowing (JSN) was seen (OR 0.97 [0.72, 1.33], P ¼ 0.869).
Conclusions: An increased prevalence of radiographic hip OA and osteophytosis was observed in HBM
cases compared with controls, in keeping with a positive association between HBM and OA and sug-
gesting that OA in HBM has a hypertrophic phenotype.
© 2014 The Authors. Published by Elsevier Ltd and Osteoarthritis Research Society International. This is
an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).o: S.A. Hardcastle, Musculo-
h Building, Southmead Hos-
. Hardcastle).
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Epidemiological studies have identiﬁed increased bone mineral
density (BMD) as a potential risk factor for osteoarthritis (OA). For
example, cross-sectional studies have demonstrated associations
between increased BMD and both radiographic hip1,2 and knee3,4
OA in a variety of populations, and longitudinal studies haveociety International. This is an open access article under the CC BY license (http://
1 Previously known as “HipMorf”.
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addition, several studies have observed a stronger association be-
tween BMD and osteophytosis than that with joint space narrowing
(JSN) (indicative of cartilage loss)1,3,9, suggesting that increased
BMD predisposes primarily to the bony features of OA. However,
while the epidemiological association between increased BMD and
radiographic OA is generally accepted, the topic remains contro-
versial as it is possible that confounding10 or reverse causality (in
cross-sectional studies) may explain the relationships observed.
Studying a high bone mass (HBM) population represents a novel
way to examine the OA-BMD relationship. As HBM is likely to be a
lifelong genetically-determined trait, and OA is a disease of later
life, this approach avoids uncertainty over the temporal sequence of
events which complicates the interpretation of previous cross-
sectional studies. Existing data on OA in association with extreme
HBM phenotypes is limited to case reports and case series, and to
our knowledge radiographic OA in a HBM population has never
been systematically studied. We previously reported an increased
prevalence of prior joint replacement, particularly hip replacement,
in HBM cases within our UK-based HBM study compared with
family controls11. While this suggests that OA risk may be elevated
in HBM, joint replacement captures only end-stage disease, and
provides limited information on OA phenotype. Recent pQCT
analysis of this same HBM population revealed increases in total
bone area in cases compared with controls suggestive of increased
periosteal apposition12, implying increased bone formation. This
raises interesting parallels with OA, as alterations in the balance
between bone formation and resorption are suggested to be a key
component of the disease13,14.
The aim of our study was to quantify and characterise radio-
graphic hip OA in a population of individuals with extreme HBM.
We wished to determine (1) whether the prevalence of radio-
graphic hip OA is increased in HBM compared with both family-
based and general population controls and (2) whether the OA
observed in HBM has a characteristic phenotype based upon indi-
vidual radiographic features of the disease. We hypothesized that
the prevalence of radiographic OA would be increased in HBM
cases, and that HBM may be associated with an excess of bone-
forming features such as osteophytes and subchondral sclerosis.
Methods
The HBM population
The HBM study is a UK-based multi-centre observational study
of adults with unexplained HBM. 335,115 DXA scans from 13 UK
DXA databases were screened for T and/or Z-scores þ4. All DXA
imageswere inspected by trained clinicians for artefactual causes of
elevated DXA BMD; 49.4% of scanswere excluded as their high T-/Z-
scores reﬂected spinal degenerative disease/osteoarthritis/scoli-
osis, and a further 15.5% for other reasons including surgical/ma-
lignant/Pagetic artefacts etc. As generalized HBM should affect both
hip and spine BMD, the HBM index case deﬁnition was reﬁned to
either a) L1 Z-score þ3.2 plus total hip Z-score þ1.2 or b) total
hip Z-score þ3.2 plus L1 Z-score þ1.2. While standard deﬁni-
tions of HBM are lacking, a þ3.2 threshold was similar to that used
in a previous publication deﬁning HBM using DXA15, and most
appropriately differentiated generalized HBM from artefact16.
Misclassiﬁcation of HBM case status due to lumbar OA was mini-
mized by using L1 Z-scorewhich, in contrast to lower lumbar levels,
was not associated with OA assessed on DXA images16,17.
Recruited index cases with unexplained HBM were asked to
invite relatives and spouses to undergo DXA screening. In ﬁrst-
degree relatives of HBM index cases, given positive affection sta-
tus within the family, HBM was deﬁned as a summed L1 Z-scoreplus total hip Z-score þ3.2. 41% of relatives screened were
affected and combined with HBM index cases; remaining unaf-
fected ﬁrst-degree relatives/spouses formed a family control group.
Full details of this DXA database screening and recruitment were
previously reported16. Assessments in both HBM cases and controls
included a structured interview and clinical examination. Supine
AP pelvic radiographs were performed in participants aged 40
years according to local protocols at each centre. Recruitment ran
from July 2005eApril 2010. Written informed consent was ob-
tained from all participants in line with the Declaration of Hel-
sinki18 and the study was approved by the Bath multi-centre
Research Ethics Committee (REC) and each NHS local REC. For
this study, HBM cases were then categorised into 5-year age bands
by gender, prior to selection of additional controls from two large
population-based cohort studies, by age and gender-stratiﬁed
random sampling.
Population-based controls
Chingford 1000 women study controls
The Chingford 1000 women study (ChS) started in 1989, initially
recruiting 1003 women aged 45e64 from the age/sex register of a
general practice in Chingford, North-East London4. 470 women
(46.9%) remained under radiographic follow-up at 20 years. Supine
pelvic radiographs were obtained in years 2, 8 and 20; radiographs
from year 20 were digital and those from years 2 and 8 latterly
digitised. Controls, according to age at the time of X-ray, were
randomly sampled in a 2:1 ratio with HBM female cases for each
age band apart from the lower (40e50 years) and upper (>80)
bands (3:1). Where a control individual had more than one pelvic
radiograph from different follow-up time-points, a single radio-
graph per participant was included; controls in the upper age bands
were selected ﬁrst to ensure sufﬁcient numbers of available X-rays.
Hertfordshire cohort study (HCS) controls
The HCS19 recruited approximately 3000 men and women born
in Hertfordshire between 1931 and 1939 and still resident there in
1998e2003. Recently a subset of HCS participants were recruited
into the European Project on Osteoarthritis (EPOSA)20, as part of
which 207 men and 203 women now aged between 71.5 years and
80.6 years had AP weight-bearing knee and/or supine pelvic X-rays
performed during 2011. These individuals were randomly sampled
2:1 with HBM cases within each appropriate age band (70e75,
75e80 and >80).
Assessment of radiographs
All available case and control radiographs were pooled for
assessment; reasons for unavailability of individual X-rays were
ascertained and recorded. Radiographs were blinded and graded in
a random order by a single observer (SH), following focussed
radiological training. Radiographic assessment was performed us-
ing OxMorf v1.6,1 a bone morphology measurement system
developed by the University of Oxford21. The software was used to
record gradings of the radiographic OA features, and to measure
minimum joint space width (JSW) quantitatively. However, as dif-
ferences in radiographic protocols between studies can result in
varying degrees of magniﬁcation of the X-ray image, we could not
reliably compare quantitative measures between studies; analysis
of measured JSWwas therefore limited to the HBM cases and family
controls only.
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score (0e5) as originally deﬁned22, followed by semi-quantitative
grading of individual radiographic features including osteophytes,
JSN, cysts and sclerosis (Table I) using an established atlas23. Cate-
gorical scores were converted to binary variables for analysis
(Table I); a Croft grade of 3 (deﬁned as two of osteophytosis, JSN,
subchondral sclerosis or cyst formation22) deﬁned the presence of
OA24. Measurement of minimum JSW involved manual placement
of two Bezier curves on the acetabular rim and femoral head by the
operatore the OxMorf software then calculated the minimum
distance between the two lines.
Image quality was rated by the operator at the time of assess-
ment (good, poor, very poor); very poor ﬁlms in terms of pene-
tration/resolution/tilt/rotationwere excluded. The presence of joint
replacements was recorded and these hips excluded from the main
analysis (a later sensitivity analysis included these ﬁlms). At the end
of the study, 5% of radiographs (n ¼ 60 ﬁlms, 119 hips [1 hip
replacement]) were re-graded, blind, to establish intra-rater
repeatability; kappa values were all >0.7 except for cysts (kappa
0.32, likely reﬂecting the very low prevalence of cysts overall)
(Supplementary Table 1). The intraclass correlation coefﬁcient (ICC)
for minimum measured JSW was 0.89.
Assessment of covariates
Values for age, gender and body mass index (BMI) were ob-
tained from each pre-existing study dataset for use in the analysis.
Age was the age in years at the time of X-ray. BMI was calculated as
weight (kg)/height (metres2) using the closest available weight and
height measurements to the time of the X-ray.
Statistical analysis
Demographic statistics for the different study populations were
summarised as mean (SD) for continuous variables and counts
(percentages) for categorical variables. In this caseecontrol anal-
ysis, categorical variables were initially cross-tabulated and per-
centages calculated. The chi-squared (c2) test was used to assess
the association between binary variables, and the unpaired t-test to
compare mean values for continuous JSW. Generalised estimating
equations (GEE) using a logistic link function (logistic regression
allowing for clustering of observations within individuals, i.e. right/
left hips) were used to examine associations between HBM case
status and the radiographic OA outcome variables. Age and genderTable I
Semi-quantitative scoring of radiographic features of hip OA. Grading of individual
radiographic features (except chondrocalcinosis) was performed using an atlas23.
Croft grading performed with reference to original published descriptions of each
grade22. The assessor was permitted to enlarge each image as necessary to visualise
the features. OP ¼ osteophyte
OA feature Categorical
grading
Binary variable (s)
Croft score
(global hip OA)
0e5 Croft score 3 (OA present)
Superior acetabular
osteophyte
0e3 Any osteophyte (any OP grade 1),
moderate osteophyte (any OP grade 2),
femoral osteophyte (any femoral OP
grade 1)
Lateral femoral
osteophyte
0e3
Medial femoral
osteophyte
0e3
JSN 0e3 Any JSN (JSN grade 1), moderate JSN
(JSN grade 2)
Subchondral sclerosis 0e1 Subchondral sclerosis (grade 1)
Cysts 0e1 Cysts (grade 1)
Chondrocalcinosis 0e1 Chondrocalcinosis (grade 1)were a priori confounders and BMI was an additional potential
confounder. Odds ratios (OR) before (model 1) and after (model 2)
adjustment are presented with 95% conﬁdence intervals (95% CI).
GEE using an identity link function (linear regression allowing for
clustering) was used to compareminimum JSW (mm) in HBM cases
and family controls, adjusting for confounders. Pre-planned sensi-
tivity analyses included (1) exclusion of ﬁlms rated as poor quality
(2) a “person-level” analysis of the worst hip in each individual (3)
adding radiographic hip replacements to the dataset, assuming
these were performed for OA (4) excluding individuals with self-
reported inﬂammatory arthritis and (5) re-deﬁning hip OA using
different Croft grade cut-offs. Interactions by age and gender were
assessed by calculating OR according to categories of each variable,
and generating a wald test P-value for appropriate interaction
terms. Datawere analysed using Stata release 12 statistical software
(StataCorp, College Station, TX, USA).
Results
Selection and characteristics of participants
Figure 1 summarises the selection of radiographs for inclusion
in our study. 56 hip joints (n ¼ 4 cases, 52 controls) were excluded
from the outset due to unacceptable image quality. Hip re-
placements were also excluded (n ¼ 16 cases, 35 controls). 2232
hips from 1135 individuals were included in the primary combined
analysis comprising 530 HBM case hips, 272 family control hips,
1091 ChS control hips and 339 HCS control hips. 1097 individuals
contributed two hips to the analysis and 38 individuals contributed
only one hip. Demographics of the study population are shown in
Table II. The combined control group was slightly older than the
cases (mean age 64.8 years vs 63.0 years) with a higher proportion
of females (84.4% vs 74.3%). As expected, cases had substantially
higher values for standardised BMD at both hip and lumbar spine
compared with controls. Cases also had a higher mean BMI
(30.5 kg/m2 vs 27.3 kg/m2), as previously reported16.
Radiographic OA in HBM cases vs controls: unadjusted analyses
The unadjusted prevalence of each radiographic OA variable in
cases was compared with that in each of the three control groups
separately and then combined (Table III). The prevalence of radio-
graphic hip OA (deﬁned as Croft score 3) was 20.0% in HBM cases
and 13.6% in the combined controls (P < 0.001). The prevalence of
any osteophyte, moderate (grade 2) osteophytes, femoral osteo-
phytes, subchondral sclerosis and chondrocalcinosis was also
greater in cases compared with combined controls. No difference
was observed between groups in the prevalence of JSN or cysts.
Radiographic OA in HBM cases vs controls: adjusted analyses
As additional adjustment for BMI gave very similar results to age
and gender adjustment alone, all three covariates were included in
our fully adjusted model. Radiographic hip OA remained more
prevalent in HBM cases comparedwith combined controls after full
adjustment (OR [95% CI] 1.52 [1.09, 2.11], P ¼ 0.013, model 2,
Table IV). In adjusted analyses of individual radiographic features of
OA, HBM cases had an increased odds compared with controls of
any osteophyte (2.12 [1.61, 2.79] P < 0.001), moderate osteophytes
(2.39 [1.72, 3.33], P < 0.001) and femoral osteophytes (1.60 [1.18,
2.17], P ¼ 0.003). Other radiographic features more prevalent in
cases compared with controls included subchondral sclerosis (2.78
[1.49, 5.18], P ¼ 0.001) and chondrocalcinosis (2.08 [1.07, 4.03],
P ¼ 0.030) although the prevalence of these features was much
lower than that of osteophytes and overall OA. In contrast, the
10 no pelvic X-
ray available6
10 excluded: 
unacceptable quality 
(2.8%)
6 hip replacements
188 controls selected
339 hips analysed
178 controls selected 
with X-ray available
410 HCS EPOSA participants 
with X-ray date5
1 hip replacement, 1 
hip incomplete data8
1158 hips
618 controls selected
579 controls selected with 
X-ray available (225 year 
2, 171 year 8, 183 year 20)
2303 Chingford female control 
X-rays within sampling frame3
1091 hips analysed
139 family controls 
with pelvic X-ray 
available
200 family controls
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4 excluded: 
unacceptable quality 
(1.4%)
272 hips analysed
16 hip 
replacements
355 HBM cases
550 hips
275 HBM cases with 
pelvic X-ray 
available
4 excluded: 
unacceptable quality 
(0.7%)
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59 no pelvic X-
ray, other reasons1
39 no pelvic X-
ray available4
21 no pelvic X-
ray, other reasons2
355 hips7
28 hip replacements, 1 
hip incomplete data9
38 excluded: 
unacceptable quality 
(3.3%)
A B C
Fig. 1. (A) Selection of HBM case and family control X-rays (process of recruitment to study previously reported16). (B) Selection of Chingford study female control X-rays. (C) Selection of HCS EPOSA male and female control X-rays.
1Reason recorded for missing X-ray in HBM cases: unable to travel (n ¼ 7), no X-rays at study centre (n ¼ 23), unable to attend/wait/comply (n ¼ 4), patient declined (n ¼ 8), not done (reason unknown) (n ¼ 9), reside abroad (n ¼ 2),
bilateral hip replacements (n ¼ 6). 2Reason recorded for missing X-ray in family controls: did not continue in study (n ¼ 1), unable to travel (n ¼ 1), no X-rays at study centre (n ¼ 9), unable to attend/wait/comply (n ¼ 2), patient
declined (n ¼ 4), not done (reason unknown) (n ¼ 3), bilateral hip replacements (n ¼ 1). 3Sampling frame constructed from dates of year 2, 8 and 20 follow-up visits supplied by study team. 4Reason recorded for missing X-ray in
Chingford controls: not found at time of request (n ¼ 6), not digitised (n ¼ 18), unknown reason (n ¼ 15). 5Sampling frame constructed from study X-ray appointment dates supplied by study team. 6Reason recorded for missing X-ray in
HCS controls: bilateral hip replacements (n ¼ 3), unknown (n ¼ 7). 7One individual contributed only one hip. 8Excluded as missing lateral femoral osteophyte variable. 9Excluded as previous fracture with ﬁxation device in situ
precluding reliable assessment.
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Table II
Demographics of study population
HBM cases
(N ¼ 272)
Family controls
(N ¼ 137)
Chingford controls (N ¼ 553) HCS controls
(N ¼ 173)
Combined controls
(N ¼ 863)
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Age (years) 63.0 (11.5) 59.9 (12.7) 62.8 (9.8) 75.2 (2.7) 64.8 (10.8)
BMI (kg/m2) 30.5 (5.7) 28.1 (4.9) 27.0 (4.6) 27.7 (4.4) 27.3 (4.7)
BMD total hip (g/cm2) 1.25 (0.17)* 0.98 (0.14)z 0.90 (0.12)x 0.96 (0.14) 0.93 (0.13)¶
BMD L1eL4 (g/cm2) 1.55 (0.18)y 1.17 (0.18)z 1.03 (0.16)k 1.09 (0.19) 1.07 (0.18)#
N (%) N (%) N (%) N (%) N (%)
Females 202 (74.3) 61 (44.5) 553 (100.0) 114 (65.9) 728 (84.4)
BMD variables standardised according to scanner type (Hologic for Chingford/HCS controls, mixed Lunar/Hologic for HBM cases and family controls) using standard equa-
tions46,47.
N for all variables is as shown except where indicated:
* N ¼ 264
y N ¼ 261
z N ¼ 136
x N ¼ 479
k N ¼ 539
¶ N ¼ 788
# N ¼ 848
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1.33], P ¼ 0.869), and there was no strong evidence of a difference
between groups in the prevalence of subchondral cysts (0.34 [0.08,
1.42], P ¼ 0.139).
Separate analyses were performed comparing the prevalence of
radiographic OA in HBM cases with that in (1) family controls
(Supplementary Table 2) (2) ChS controls (females only,
Supplementary Table 3) (3) HCS controls (Supplementary Table 4),
and (4) between HBM male cases and all male controls
(Supplementary Table 5). Findings were broadly consistent across
these different subgroups, although conﬁdence intervals were
generally widened. The fully adjusted OR for hip OA was lower for
HBM cases vs family controls (1.32 [0.77, 2.27], P ¼ 0.318) than for
HBM cases vs all pooled controls, however osteophytes remained
strongly associated with HBM case status and the OR for sub-
chondral sclerosis was similar to that seen overall. Minimum
measured JSW did not differ between HBM cases and family con-
trols (Supplementary Table 2). Restricting analyses to those HBM
individuals aged 65 years vs HCS controls (due to the older age
range of the HCS population, Supplementary Table 4) resulted in
small numbers; whilst the OR for hip OAwas attenuated (1.14 [0.70,
1.86], P ¼ 0.608), a strong association persisted for the osteophyte
variables.
Interaction with age and gender
The suggestion that the association of radiographic OA with
HBM is attenuated in older individuals was explored by examining
age interactions in analyses comparing HBM cases with combined
controls. Some evidence of a HBM-age interaction was found, with
the odds of OA in cases vs controls greater in the younger age
groups (Fig. 2; wald test P value for interaction term 0.04), sug-
gesting that HBM casesmay develop OA at an earlier age.Whilst the
overall prevalence of hip OA was greater in males compared with
females (27.5% and 12.4% respectively), there was no evidence of a
gender interaction (P ¼ 0.59).
Sensitivity analyses
31 case hips (5.7%) and 229 control hips (13.5%) were of poor
quality in terms of resolution/penetration/artefact. Excluding these
ﬁlms resulted in point estimates that were essentially unchanged
(OR for hip OA 1.57 [1.10, 2.23], P¼ 0.012; any osteophyte 2.14 [1.59,
2.88], P < 0.001; subchondral sclerosis 2.94 [1.52, 5.67], P ¼ 0.001)(model 2). A person-level analysis of the worst hip per participant,
also resulted in very similar point estimates (adjusted OR for hip OA
1.61 [1.14, 2.26, P ¼ 0.007; any osteophyte 2.79 [1.91, 4.06],
P < 0.001; subchondral sclerosis 2.40 [1.30, 4.43], P ¼ 0.005).
Although hip replacements were excluded from the main analysis,
a sensitivity analysis was performed in which these hips were
included, with total hip replacements (n¼ 50) assumed to have OA.
This resulted in a small increase in the OR for hip OA in HBM (1.58
[1.15, 2.17], P ¼ 0.005, model 2, Supplementary Table 6). For HBM
study cases and controls only, data on self-reported inﬂammatory
arthritis were available. Excluding the hips of these individuals
from the analysis (N ¼ 35 HBM cases, two family controls) resulted
in only minor attenuation of the OR for hip OA overall
(Supplementary Table 7), whilst a strong association with osteo-
phytosis persisted; numbers for this analysis were comparatively
small.
The effect of applying different Croft grade cut-offs for radio-
graphic hip OA is shown in Supplementary Table 8; if the Croft
grade 3 deﬁnition was modiﬁed to require the presence of JSN
(grade 1), there was little evidence of attenuation (OR 1.42 [1.02,
1.98], P ¼ 0.038). Deﬁning radiographic hip OA as Croft grade 4
(“severe radiographic OA”25) strengthened the association with
HBM (OR 1.99 [1.04, 3.81], P¼ 0.037), whereas a deﬁnition based on
Croft grade 226 resulted in no association between HBM and hip
OA (OR 1.04 [0.76, 1.41], P ¼ 0.802).
Discussion
Our data are the ﬁrst to support an increased prevalence of
radiographic hip OA in a population of extreme HBM cases,
compared with controls. Furthermore, features of OA reﬂecting
excess bone formation (osteophytes and subchondral sclerosis)
were more strongly associated with HBM case status than other OA
features such as JSN and cysts, for which no clear association was
seen. Taken with results from our recent pQCT study12, these
ﬁndings suggest that increased bone formation is a key feature of
the HBM phenotype, which in turn leads to a greater risk of OA.
HBM was suggested to represent an incidental ﬁnding when orig-
inally described16, but our present results ﬁt with more recent
evidence that it is associated with signiﬁcant co-morbidities11,27.
Our ﬁndings were generally consistent throughout the different
control groups, other than HBM cases being more similar to family
controls than to general population controls (a ﬁnding likely to be
explained by shared genetic and environmental factors).
Table III
Prevalence of hip OA features in HBM cases and control groups
HBM cases
(N ¼ 530)
Family controls
(N ¼ 272)
Chingford controls
(N ¼ 1091)
HCS controls
(N ¼ 339)
Combined controls
(N ¼ 1702)
N (%) N (%) c2 P N (%) c2 P N (%) c2 P N (%) c2 P
Croft score 3 106 (20.0) 46 (16.9) 0.291 102 (9.4) <0.001 83 (24.5) 0.118 231 (13.6) <0.001
Osteophyte (any) 373 (70.4) 166 (61.0) 0.008 546 (50.5) <0.001 225 (66.4) 0.214 937 (55.1) <0.001
Moderate (grade 2) osteophyte 117 (22.1) 32 (11.8) <0.001 97 (8.9) <0.001 52 (15.3) 0.014 181 (10.6) <0.001
Any femoral osteophyte 108 (20.4) 36 (13.2) 0.013 115 (10.5) <0.001 76 (22.4) 0.472 227 (13.3) <0.001
JSN (any) 116 (21.9) 55 (20.2) 0.585 173 (15.9) 0.003 125 (36.9) <0.001 353 (20.7) 0.572
Moderate (grade 2) JSN 22 (4.2) 8 (2.9) 0.393 20 (1.8) 0.006 22 (6.5) 0.125 50 (2.9) 0.167
Cysts 2 (0.4) 2 (0.7) 0.496 14 (1.3) 0.084 5 (1.5) 0.077 21 (1.2) 0.088
Sclerosis 30 (5.7) 7 (2.6) 0.049 16 (1.5) <0.001 13 (3.8) 0.226 36 (2.1) <0.001
Chondrocalcinosis 24 (4.5) 7 (2.6) 0.174 27 (2.5) 0.026 12 (3.5) 0.476 46 (2.7) 0.035
Mean (SD) Mean (SD) Py Mean (SD) P Mean (SD) P Mean (SD) P
Measured JSW (mm)* 3.05 (0.71) 3.06 (0.68) 0.754 e e e e e e
P values refer to comparison with HBM cases. N for all variables is as shown except where indicated and refers to number of hip joints analysed.
* Quantitative measurement of JSW limited to HBM study participants (HBM cases and family controls) only; N ¼ 526 (HBM cases), 270 (family controls).
y P value from unpaired t-test.
S.A. Hardcastle et al. / Osteoarthritis and Cartilage 22 (2014) 1120e1128 1125Associations between HBM and radiographic features of hip OA
persisted following adjustment for the confounders age, gender
and BMI.
The extent to which ﬁndings in this extreme HBM group can be
generalised to populations with a more typical BMD distribution is
uncertain. Our observation that OA in HBM appeared to be pri-
marily characterised by osteophytes rather than JSN likely reﬂects
relationships between OA and BMD in the wider population, as
osteophytes were reportedly more strongly associated with
increased BMD than JSN in previous population-based studies1,3,9.
JSN is considered the best radiographic surrogate of cartilage loss28,
and is arguably a prerequisite for the deﬁnition of hip OA29. Our
failure to ﬁnd evidence of differences in JSN between groups might
reﬂect methodological limitations. Assessment of JSN on radio-
graphs is insensitive to early cartilage changes in comparison to
MRI-based and arthroscopic methods30,31, and while measurement
of minimum JSW may have been more sensitive than semi-
quantitative JSN assessment, unfortunately we were only able to
compare this outcome in HBM cases and family controls.
Alternatively, it is possible that HBM predisposes primarily to
the bony features of OA and not to cartilage loss. A distinction hasTable IV
GEE regression analysis of radiographic hip OA variables in HBM cases vs all com-
bined controls. Results show OR, with 95% conﬁdence interval (95% CI). N (total no.
of hip joints analysed) ¼ 530 (HBM cases), 1702 (controls). Model 1 ¼ unadjusted,
model 2 ¼ adjusted for age, gender and BMI. GEE ¼ Generalised estimating equa-
tions with logistic link function
Outcome Model OR (95% CI) in HBM
cases vs controls
P
Croft score 3 1 1.58 (1.17, 2.14) 0.003
2 1.52 (1.09, 2.11) 0.013
Osteophyte (any) 1 1.94 (1.51, 2.49) <0.001
2 2.12 (1.61, 2.79) <0.001
Moderate (grade 2) osteophyte 1 2.35 (1.72, 3.21) <0.001
2 2.39 (1.72, 3.33) <0.001
Any femoral osteophyte 1 1.66 (1.23, 2.23) 0.001
2 1.60 (1.18, 2.17) 0.003
JSN (any) 1 1.08 (0.81, 1.43) 0.598
2 0.97 (0.72, 1.33) 0.869
Moderate (grade 2) JSN 1 1.44 (0.82, 2.53) 0.206
2 1.48 (0.82, 2.69) 0.196
Cysts 1 0.30 (0.07, 1.28) 0.104
2 0.34 (0.08, 1.42) 0.139
Sclerosis 1 2.81 (1.54, 5.13) 0.001
2 2.78 (1.49, 5.18) 0.001
Chondrocalcinosis 1 1.62 (0.86, 3.05) 0.135
2 2.08 (1.07, 4.03) 0.030been made in the literature between the relationship of increased
BMDwith incident knee OA (increased) and progression of existing
knee OA (possibly reduced)5,6 and, interestingly, a recent study
reported a positive association between systemic BMD and MRI-
measured cartilage thickness in radiographic knee OA, possibly
indicating a protective role for BMD against cartilage degradation in
established disease32. Similarly, although osteophytes and JSN are
generally associated, not all joints with osteophytes progress over
time to develop the other structural changes of OA33,34. Osteo-
phytes may even have a positive role in stabilising the OA joint
against further deterioration35, possibly explaining why “atrophic”
hip OA lacking osteophytes may progress more rapidly than hy-
pertrophic forms of the disease36,37. Against this hypothesis is our
previous ﬁnding of increased joint replacement in HBM cases11
supporting an increase in clinically signiﬁcant OA in HBM,
although it is worth noting that bony changes of OA may them-
selves be an important source of pain38,39 and furthermore that
more severe radiographic appearances may affect the decision to
offer joint replacement surgery40.
How radiographic hip OA should be deﬁned remains a matter of
debate and, as we expected, the OA deﬁnition used affected the
strength of association with HBM that we observed. A more strin-
gent Croft grade cut-off of 4 strengthened the associationFig. 2. Figure shows OR for hip OA (deﬁned as Croft score 3) in HBM cases vs con-
trols, according to age group, adjusted for gender and BMI. <50 y n (no. of hips) ¼ 324,
81.5% female; 50e60 y n ¼ 420, 89% female; 60e70 y n ¼ 669, 87.4% female; >70 y
n ¼ 819, 74% female. GEE used to account for within participant clustering (left/right).
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(allowing OA to be deﬁned by JSN alone) resulted in no association;
this deﬁnition would include atrophic OA29,41, which might
potentially have distinct risk factors. Indeed it was recently re-
ported in a large population-based cohort that atrophic hip OAmay
actually be associated with lower BMD42. Deﬁning hip OA as a Croft
grade3 but with JSN as one of the two required features, is closest
to the deﬁnition of “composite OA” proposed by Javaid41, since the
second feature in the vast majority of cases will be osteophytes.
Deﬁnitions of hypertrophic OA have focussed on osteophytes,
particularly femoral osteophytes29,41, however whereas some au-
thors have deﬁned hypertrophic OA as osteophytosis in the absence
of JSN29,41, other deﬁnitions have required both osteophytes and
JSN to be present43. In our study, deﬁning hypertrophic OA as
femoral osteophytosis without JSN strengthened the HBM-OA as-
sociation (OR 1.69 [1.18, 2.43], P¼ 0.005). Therefore HBM appears to
be associated with both composite and hypertrophic, but not
atrophic, hip OA phenotypes.
As outlined in our introduction, extreme HBM is likely to be
genetically determined with onset of elevated bone mass relatively
early in life; the genetic basis of increased BMD in our HBM pop-
ulation is currently being investigated. Therefore, despite the cross-
sectional nature of this analysis, we assume the relationships that
we found reﬂect either a causal pathway between higher BMD and
increased risk of OA, or genetic pleiotropy. However, it remains
theoretically possible that local features of OA at the hip and/or
lumbar spine, such as osteophytes, subchondral sclerosis and but-
tressing (in which osteophytes at the hip joint extend across the
femoral neck), could have led to artefactual elevation of DXA BMD
resulting in misclassiﬁcation of case status. If this were the case, a
spurious HBM-OA association could be induced. Every effort was
made within the study design to avoid this; DXA scans were visu-
ally inspected for artefactual causes of raised BMD including sig-
niﬁcant OA, and the L1 vertebra was selected for the case deﬁnition
as L1 Z-score was not associated with features of OA visible on
lumbar DXA16,17. In fact, this approach may have led to some in-
dividuals with both HBM and OA being excluded, which if anything
would bias the results of the present study towards the null.
Reassuringly, limited evidence from the literature suggests that hip
OA has only a minimal inﬂuence on measured hip BMD44, and no
association was observed between hip OA and ipsilateral total hip
Z-score when HBM study participants were stratiﬁed by case status
implying that hips affected and unaffected by OA had similar de-
grees of BMD elevation (Supplementary Table 9).
The fact that HBM cases were identiﬁed from a DXA population
whereas controls came from other sources is a limitation of this
study; whilst both ChS and HCS are thought to be broadly repre-
sentative of the UK population4,19, we cannot exclude the possi-
bility that OA risk in a population referred for DXA scanningmay be
different. In addition, some radiographs for both cases and controls
were unavailable (Fig. 1). Less mobile participants with OA may
have been less likely to have attended for X-rays, and there was
evidence in the HBM and HCS groups that hip replacements were
less likely to be X-rayed, although numbers missing for this reason
were small. In addition, our sampling strategy for the ChS controls
(later X-rays selected ﬁrst) was unavoidably biased towards those
women with continued follow-up, possibly resulting in a “healthy
cohort” effect. Both of these factors would have led to underesti-
mation of the true OA prevalence amongst the population controls.
However, as only 41% of HBM cases initially identiﬁed from DXA
database screening were recruited into the HBM study16, partici-
pation bias in the same direction is likely to have affected the HBM
group. A single observer graded all radiographs, which may have
led to either over or underestimation of the prevalence of OA but
should not have affected between-group differences; this strategywas chosen as intra-rater repeatability of semi-quantitative OA
scoring is known to be substantially superior to that between ob-
servers45. Although every effort was made to blind the assessor to
caseecontrol status, complete blinding may have been lost for
some older, poorer quality control images. Lastly, this study did not
attempt to examine associations between radiographic OA and
clinical features such as pain (howeverwe have previously reported
a comparison of clinical OA phenotypes including joint pain in HBM
cases vs family controls11).
In conclusion, we have observed an increased prevalence of
radiographic hip OA in HBM cases compared with both family-
based and general population controls. In addition, those features
of OA arising from increased bone formation, including osteophytes
and subchondral sclerosis, were particularly strongly associated
with HBM suggesting that hip OA in this group has a hypertrophic
phenotype. These data support a true association between
increased BMD and OA, and suggest that common underlying
mechanisms relating to bone mass regulation may underpin both
HBM and hypertrophic OA.
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